Showing results (1-10 of 1,181) with videos related to
Sort By:
Pageof 119
Lancet (London, England)|September 25, 2023
CAR T-cell therapy in autoimmune diseasesGeorg Schett, Andreas Mackensen, Dimitrios MougiakakosThe Lancet. Neurology|May 17, 2024
B cell-targeting chimeric antigen receptor T cells as an emerging therapy in neuroimmunological diseasesAiden Haghikia, Georg Schett, Dimitrios MougiakakosBlood|December 19, 2024
CAR T cells in autoimmunity: game changer or stepping stone?Dimitrios Mougiakakos, Everett H Meyer, Georg SchettJCI Insight|May 9, 2024
Selective CAR T cell-mediated B cell depletion suppresses IFN signature in SLEArtur Wilhelm, David Chambers, Fabian Müller, et al.Innere Medizin (Heidelberg, Germany)|June 30, 2025
[CAR T cells in non-malignant diseases]Fabian Müller, Melanie Hagen, Georg Schett, et al.Frontiers in Oncology|November 30, 2020
Linking Immunoevasion and Metabolic Reprogramming in B-Cell-Derived LymphomasMartin Böttcher, Rebecca Baur, Andrej Stoll, et al.Frontiers in Immunology|November 15, 2021
T-Cell Metabolism in Graft <i>Versus</i> Host DiseaseFranziska Karl, Michael Hudecek, Friederike Berberich-Siebelt, et al.Cancers|November 11, 2022
Role of CAR T Cell Metabolism for Therapeutic EfficacyJudit Rial Saborido, Simon Völkl, Michael Aigner, et al.Stem Cells (Dayton, Ohio)|April 30, 2020
N-glycosylation controls inflammatory licensing-triggered PD-L1 upregulation in human mesenchymal stromal cellsVivien Strauch, Domenica Saul, Mirjeta Berisha, et al.Oncotarget|March 24, 2018
IL-21 modulates memory and exhaustion phenotype of T-cells in a fatty acid oxidation-dependent mannerRomy Loschinski, Martin Böttcher, Andrej Stoll, et al.Pageof 119